Hot Products

Erycibelline
Catalog No: CFN00157

Erycibelline has antiobesity activity, it may be a useful therapeutic agent for body weight control by downregulating adipogenesis and lipogenesis.

Erythrinin C
Catalog No: CFN97096

Standard reference

Erythristemine
Catalog No: CFN98351

(+)-Erythristemine shows moderate toxicity to brine shrimp (LC50 23 ppm) and moderate (IC50=86microg/ml) radical scavenging properties against stable 2,2-diphenyl-1-picrylhy--drazyl (DPPH) radical.

Erythritol
Catalog No: CFN99620

Erythritol is a biological sweetener with applications in food and pharmaceutical industries, it is also used as a functional sugar substitute in special foods for people with diabetes and obesity because of its unique nutritional properties. Erythritol consumption acutely improved small vessel endothelial function, and chronic treatment reduced central aortic stiffness, may be as a preferred sugar substitute for patients with diabetes mellitus.

Erythrodiol
Catalog No: CFN98914

Erythrodiol is the precursor of pentacyclic triterpenic acids, it exerts antiproliferative and proapoptotic activity in colon adenocarcinoma cells. Erythrodiol may have interesting therapeutic potential as new vasodilator drugs, thus protecting the cardiovascular system.

Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether
Catalog No: CFN95416

Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether,cytotoxic effects on human cancer cell lines

Erythrosin B
Catalog No: CFN91670

Erythrosine B is an artificial dye widely used in the food and textile industries. Erythrosine B is also a novel photosensitizer which has been used to develop animal models.Erythrosin B, a potent inhibitor for flaviviruses.Erythrosin B can act as a central excitatory agent able to induce hyperkinetic behavior.

Eschweilenol C
Catalog No: CFN95363

Eschweilenol C has antifungal, anti-inflammatory, antioxidant, antidiabetic activity. 4-(alpha-rhamnopyranosyl)ellagic acid is an inhibitor of human recombinant aldose reductase HRAR (IC50 = 4.1 x 10(-8) M).

Escin IA
Catalog No: CFN93368

Escin IA is a prodrug and its structure can be converted to desacylescin I by human intestinal bacteria and Lactobacillus brevis., desacylescin I as a biotransformation product shows potentially inhibitory effects on mouse tumor, and a potential candidate for anti tumor agents. Escin IA has anti-TNBC metastasis activity, and its action mechanisms involved inhibition of EMT process by down-regulating LOXL2 expression.

Escin IB
Catalog No: CFN90934

Escin Ib inhibits gastric emptying, at least in part, mediated by capsaicin-sensitive sensory nerves, to stimulate the synthesis and/or release of dopamine, to act through central dopamine2 receptor, which in turn causes the release of PGs.